Pharma Pulse 6/10/25: Exploring Perspectives of Fair Market Value in Clinical Trial Budgeting; New Technology Helps Prevent Opioid Overdose

Exploring Perspectives of Fair Market Value in Clinical Trial Budgeting

An Applied Clinical Trials article explores the complex and often conflicting perspectives of sponsors, CROs, and research sites on fair market value in clinical trial budgeting, emphasizing the need for transparency, flexibility, and collaboration to ensure sustainable and equitable compensation practices across the global research landscape.

Because Ned Said: New Technology Helps Prevent Opioid Overdose

An article in Pharmacy Times by Ned Milenkovich highlights how a new drug delivery technology, LIMITX—developed by Acura Pharmaceuticals and licensed to Abuse Deterrent Pharma—is designed to reduce peak blood concentrations of hydrocodone during overdose attempts, offering a potential breakthrough in preventing opioid-related deaths.

Treating Symptoms to Precision Medicine: The Path Forward

A Pharmaceutical Executive article recounts a former ICU physician’s transition to drug development at Biohaven, highlighting how advances in precision medicine—particularly through targeted extracellular protein degradation—are enabling faster, more effective treatments that directly address the root causes of autoimmune and inflammatory diseases.

Pharmacists Help Patients Manage Chronic Pain

A Drug Topics article highlights the vital role pharmacists play in managing chronic pain, showing how their expertise in medication review, patient education, and collaborative prescribing significantly improves outcomes, reduces opioid use, and enhances quality of care across clinical and community settings.

Drug Imports Plummeted in April Despite Tariff Threat

Drug imports to the US sharply declined in April following a March surge, as manufacturers likely pulled back from stockpiling amid a temporary tariff pause, potential overfilled inventories, and limited production capacity in key regions.